Cigna earnings beat by $0.04, revenue topped estimates
Scott Farquhar, a director and ten percent owner at Atlassian Corp (NASDAQ:TEAM), recently executed a series of stock sales totaling approximately $1.77 million. These transactions, conducted on April 2, involved the sale of Class A Common Stock at prices ranging from $216.76 to $226.565 per share. The stock, which commands a market capitalization of nearly $59 billion, has since declined to $198.29, though InvestingPro data shows impressive gross profit margins of 82% and strong revenue growth of 23% year-over-year.
The sales were carried out under a Rule 10b5-1 trading plan, which was adopted by Farquhar in February 2024. Following these transactions, Farquhar retains ownership of 357,660 shares, held indirectly by the Farquhar Family Trust.
Investors may recognize these sales as part of regular portfolio management and personal financial planning by executives.
In other recent news, Atlassian Corporation reported impressive financial results for Q4 2024, surpassing both earnings and revenue forecasts. The company’s earnings per share reached $0.96, significantly beating the forecasted $0.62, while revenue hit $1.29 billion, exceeding expectations of $1.23 billion. Additionally, Atlassian’s subscription revenue grew by 30% year over year, contributing to improved gross margins of 85%. In the realm of analyst activity, UBS adjusted its price target for Atlassian from $330 to $230, maintaining a neutral rating, while Stephens initiated coverage with an Equal Weight rating and a $255 price target, emphasizing the company’s broad Total (EPA:TTEF) Addressable Market. KeyBanc Capital Markets maintained an Overweight rating with a $365 price target, highlighting Atlassian’s attractive risk/reward balance despite recent market volatility. These developments reflect a mix of optimism and caution among analysts regarding Atlassian’s stock, with attention focused on the company’s upcoming financial disclosures and strategic initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.